T 1105,
T-1105,
T1105 cpd,
3-Hydroxypyrazine-2-carboxamide,
55321-99-8,
2-oxo-1H-pyrazine-3-carboxamide,
3-Oxo-3,4-dihydropyrazine-2-carboxamide,
Pyrazinecarboxamide, 3,4-dihydro-3-oxo-,
NSC163503,
T-1105,
SZPBAPFUXAADQV-UHFFFAOYSA-N,
Pyrazine-2-carboxamide, 3-hydroxy-,
MFCD00233977,
t6mv dnj cvz[wln],
3-HYDROXYPYRAZINE-2-CARBOXAMINE,
AC1Q6FTJ,
AC1L6MD7,
KSC273I6F,
SCHEMBL1338425,
ZINC8657,
3-Hydroxy-2-pyrazinecarboxamide,
CTK1H3462,
3-hydroxy-pyrazine-2-carboxamide,
DTXSID10203888,
2-Pyrazinecarboxamide, 3-hydroxy-,
3-Hydroxy-2-pyrazinecarboxamide #,
BCP03021,
KS-00000B7C,
ANW-32293,
CH-048,
CH0047,
QC-267,
SBB086051,
AKOS005166970,
AKOS015950901,
AN-1706,
CS-W016480,
NSC-163503,
TRA0089702,
3,4-Dihydro-3-oxo-2-pyrazinecarboxamide,
AC-25579,
AJ-08315,
AK-39215,
CJ-00121,
SY017450,
ZB000668,
AB0025466,
AB1006173,
DB-000194,
RT-003991,
ST2405101,
4CH-001068,
AM20070364,
FT-0686914,
W6935,
MFCD00233977 (98%),
T 1105,
W-4008,
321H998,
Q-103306,
I14-57221,
null,
D09VHW,
D0S5RY,
C5H5N3O2,
AR-1L5813,
CID294642,
ACN-029288,
CB10307,
H1485,
3-Hydroxypyrazine-2-carboxamide, 98% 250mg,
S 3025,
3-Hydroxypyrazine-2-carboxamide, 97% - 1G 1g,
Pyrazinecarboxamide, 3,4-dihydro-3-oxo- (9CI),
2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1),
1237524-82-1,
55733-18-1,